Sino Biopharmaceutical Stock price
Compare with Peer Group
AI Insights on Sino Biopharmaceutical
Insights
Is Sino Biopharmaceutical a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?
As a Free StocksGuide user, you can view scores for all 9,127 stocks worldwide.
Key metrics
Sino Biopharmaceutical Stock Analysis
Analyst Opinions
31 Analysts have issued a Sino Biopharmaceutical forecast:
Analyst Opinions
31 Analysts have issued a Sino Biopharmaceutical forecast:
Don't miss a Thing! We will send you all news about Sino Biopharmaceutical directly to your mailbox free of charge.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Sino Biopharmaceutical Stock News
Company Profile
Sino Biopharmaceutical Ltd. is an investment holding company, which engages in the manufacture and sale of pharmaceutical products. It operates through the following business segments: Modernised Chinese Medicines and Chemical Medicines, Investment, and Others. The Modernised Chinese Medicines and Chemical Medicines segment comprises the manufacturing, selling, and distribution of modernized Chinese medicine products and western medicine products. The Investment segment offers long term investments. The Other segment includes a research and development sector, which provides services to third-parties; and related healthcare and hospital business. It also develops medicines for treating tumors, analgesia, diabetes, and respiratory system diseases. The company was founded by Ping Tse on February 2, 2000 and is headquartered in Hong Kong.
| Head office | Cayman Islands |
| CEO | Mr. Tse |
| Employees | 21,435 |
| Founded | 2000 |
| Website | www.sinobiopharm.com |


